FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.2  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Nitrofurantoin 50mg capsules (Morningside Healthcare Ltd) 30 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitrofurantoin 50mg capsules (Morningside Healthcare Ltd) 30 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitrofurantoin 100mg capsules (Morningside Healthcare Ltd) 30 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitrofurantoin 100mg capsules (Morningside Healthcare Ltd) 30 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Allopurinol 100mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Allopurinol 100mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Allopurinol 300mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Allopurinol 300mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 200mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 200mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 1mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 1mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 1mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Fluoxetine 10mg capsules (Morningside Healthcare Ltd) 30 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Fluoxetine 10mg capsules (Morningside Healthcare Ltd) 30 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 50 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 50 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 250mg tablets (Ennogen Pharma Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 250mg tablets (Ennogen Pharma Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Viatris UK Healthcare Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Viatris UK Healthcare Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Viatris UK Healthcare Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Viatris UK Healthcare Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Viatris UK Healthcare Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Viatris UK Healthcare Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 4mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 4mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Furosemide 20mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Furosemide 20mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 125mg tablets (Ennogen Pharma Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 125mg tablets (Ennogen Pharma Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 500mg tablets (Ennogen Pharma Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 500mg tablets (Ennogen Pharma Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitrazepam 5mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitrazepam 5mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ranitidine 150mg tablets (Ennogen Pharma Ltd) 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ranitidine 150mg tablets (Ennogen Pharma Ltd) 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 250mg gastro-resistant tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 250mg gastro-resistant tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 8mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 8mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    CanesOasis Cystitis Relief 4g oral granules sachets (Bayer Plc) 6 sachet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    CanesOasis Cystitis Relief 4g oral granules sachets (Bayer Plc) 6 sachet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 250mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 250mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ocufresh 0.3% eye drops (Blumont Healthcare Ltd) 10 ml Has concentration strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ocufresh 0.3% eye drops (Blumont Healthcare Ltd) 10 ml Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Melkine 1.5mg tablets (Crescent Pharma Ltd) 1 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Melkine 1.5mg tablets (Crescent Pharma Ltd) 1 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Allerief 4mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Allerief 4mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 60 tablet 6 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 60 tablet 6 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Paracetamol 500mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Paracetamol 500mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Paracetamol 500mg tablets (Medreich Plc) 32 tablet 4 x 8 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Paracetamol 500mg tablets (Medreich Plc) 32 tablet 4 x 8 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Paracetamol 500mg tablets (Medreich Plc) 16 tablet 2 x 8 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Paracetamol 500mg tablets (Medreich Plc) 16 tablet 2 x 8 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cimetidine 200mg tablets (Medreich Plc) 60 tablet 3 x 20 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cimetidine 200mg tablets (Medreich Plc) 60 tablet 3 x 20 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cimetidine 400mg tablets (Medreich Plc) 60 tablet 6 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cimetidine 400mg tablets (Medreich Plc) 60 tablet 6 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Losartan 100mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Losartan 100mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 500mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 500mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 3mg buccal tablets (Medreich Plc) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 3mg buccal tablets (Medreich Plc) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 5mg tablets (Medreich Plc) 84 tablet 6 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 5mg tablets (Medreich Plc) 84 tablet 6 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ibuprofen 400mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ibuprofen 400mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ibuprofen 600mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ibuprofen 600mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cimetidine 800mg tablets (Medreich Plc) 30 tablet 3 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cimetidine 800mg tablets (Medreich Plc) 30 tablet 3 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Isosorbide mononitrate 20mg tablets (Medreich Plc) 56 tablet 4 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Isosorbide mononitrate 20mg tablets (Medreich Plc) 56 tablet 4 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Hydroxyzine 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Hydroxyzine 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Losartan 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Losartan 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Losartan 50mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Losartan 50mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tetracycline 250mg tablets (Genesis Pharmaceuticals Ltd) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tetracycline 250mg tablets (Genesis Pharmaceuticals Ltd) 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 316 of 342 Next End

    This concept is not in any reference sets

    Back to Start